- Home
- LFVN vs SERA Comparison
LFVN vs SERA Comparison
Compare LFVN & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LFVN | SERA |
|---|---|---|
| Founded | N/A | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precision Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.0M | 75.2M |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | LFVN | SERA |
|---|---|---|
| Price | $6.53 | $2.05 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $11.00 | N/A |
| AVG Volume (30 Days) | ★ 215.3K | 30.7K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.56% | N/A |
| EPS Growth | ★ 226.09 | 32.32 |
| EPS | ★ 0.30 | N/A |
| Revenue | ★ $203,204,000.00 | $81,000.00 |
| Revenue This Year | N/A | $554.81 |
| Revenue Next Year | N/A | $517.27 |
| P/E Ratio | $20.90 | ★ N/A |
| Revenue Growth | 1.86 | ★ 5.19 |
| 52 Week Low | $3.90 | $1.56 |
| 52 Week High | $15.00 | $3.95 |
Technical Indicators
Market Signals| Indicator | LFVN | SERA |
|---|---|---|
| Relative Strength Index (RSI) | 46.35 | 52.76 |
| Support Level | $5.93 | $1.68 |
| Resistance Level | $6.41 | $2.40 |
| Average True Range (ATR) | 0.23 | 0.19 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 77.78 | 55.39 |
Price Performance
Historical ComparisonAbout LFVN Lifevantage Corporation (Delaware)
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.